• Dextromethorphan Hydrobromide: Technical Use in Neuroprotect

  2026-04-27

  Dextromethorphan hydrobromide is a high-purity NMDA receptor antagonist used for controlled studies of neuroprotection, excitotoxicity inhibition, and ion channel modulation in neuroscience research. It is not intended for diagnostic, clinical, or therapeutic use, and optimal results depend on strict adherence to solubility, storage, and protocol parameters.

• Dextromethorphan hydrobromide: Technical Guide for Research

  2026-04-27

  Dextromethorphan hydrobromide is a high-purity NMDA receptor antagonist suited for controlled studies of neuroprotection, excitotoxicity inhibition, and ion channel modulation. It should be used strictly in preclinical laboratory workflows, not for clinical or diagnostic applications, with careful adherence to solubility, storage, and assay protocols.

• PR-619: Precision Deubiquitylating Enzymes Inhibition for Co

  2026-04-26

  Explore the advanced use of PR-619 as a deubiquitylating enzymes inhibitor in next-generation ubiquitination pathway research. This article uniquely addresses solubility, protocol optimization, and translational implications, offering perspectives not found in existing literature.

• Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry

  2026-04-25

  Wang et al. (2018) established that genotype III grass carp reovirus (GCRV104) enters fish kidney cells via clathrin-mediated, pH-dependent endocytosis, using a systematic inhibitor analysis. The findings clarify viral entry mechanisms and provide a basis for targeted antiviral research in aquaculture.

• Optimizing Polyadenylated mRNA Assays with ARCA EGFP mRNA (5

  2026-04-24

  ARCA EGFP mRNA (5-moUTP) stands out as a robust, low-immunogenicity reporter for fluorescence-based transfection control in mammalian cells. Its advanced cap structure and nucleotide modifications offer reproducible, high-efficiency expression—making it the gold standard for benchmarking mRNA delivery workflows.

• Isoliensinine Attenuates Hepatic Fibrosis via TRPV1–AMPK Pat

  2026-04-24

  This study demonstrates that isoliensinine, derived from Plumula Nelumbinis, mitigates hepatic fibrosis in metabolic associated fatty liver disease (MAFLD) by modulating lipid droplet metabolism. Mechanistically, the research uncovers a TRPV1–AMPK signaling axis critical for restoring lipid homeostasis and suppressing hepatic stellate cell activation, offering a novel therapeutic angle for metabolic disease research.

• (-)-JQ1: Benchmark Negative Control for BET Bromodomain Assa

  2026-04-23

  (-)-JQ1, the gold-standard JQ1 stereoisomer from APExBIO, is the definitive negative control in BRD4 and BET bromodomain inhibitor studies. Its precise inactivity equips researchers to dissect on-target epigenetic and cancer biology effects with unmatched experimental rigor.

• Temafloxacin: Fluoroquinolone Broad-Spectrum Antibacterial A

  2026-04-23

  Temafloxacin stands out as a robust fluoroquinolone broad-spectrum antibacterial agent with exceptional potency against both Gram-positive and Gram-negative pathogens. This article provides actionable experimental workflows, optimization tips, and troubleshooting strategies, helping researchers maximize data quality and reproducibility in antibacterial and intracellular assay applications.

• SP600125: Selective JNK Inhibitor for Apoptosis and Inflamma

  2026-04-22

  SP600125 is a potent, ATP-competitive JNK inhibitor with validated selectivity for JNK1, JNK2, and JNK3. It enables precise modulation of apoptosis and cytokine expression in both cellular and animal models. This article details its mechanism, evidence base, and practical considerations for research use.

• HotStart Universal 2X Green qPCR Master Mix in Neurogenetic

  2026-04-22

  Explore how HotStart Universal 2X Green qPCR Master Mix revolutionizes real-time PCR gene expression analysis in neurogenetics. This article uniquely integrates insights from advanced NEXMIF research, offering practical and technical guidance for robust assay design.

• (-)-JQ1: Elevating BET Bromodomain Rigor in Translational On

  2026-04-21

  This thought-leadership article explores the mechanistic and strategic imperatives of deploying (-)-JQ1, the gold-standard inactive control for BET bromodomain inhibition, in advanced cancer biology research. Drawing on the latest findings from HPV-16 associated HNSCC and integrating lessons from leading control compound strategies, we reveal how rigorous use of (-)-JQ1 enables unprecedented specificity and translational relevance in BRD4-targeted studies. The article frames new standards for experimental design, reproducibility, and clinical insight—offering actionable guidance for translational researchers navigating the evolving epigenetics landscape.

• Cyclo (-RGDfC) in Translational Oncology: Precision Tools an

  2026-04-21

  Explore the unique role of Cyclo (-RGDfC) in integrin-mediated cell adhesion and tumor targeting peptide research. This article delivers advanced assay strategies, protocol guidance, and practical insights distinct from standard reviews.

• Homologous Recombination Defects and Olaparib Sensitivity in

  2026-04-20

  Borchert et al. (2019) identified that a subset of malignant pleural mesothelioma (MPM) tumors with homologous recombination repair (HRR) pathway defects—termed 'BRCAness'—are susceptible to apoptosis and growth inhibition via olaparib treatment, especially in BAP1-mutated cells. Their findings suggest a rationale for precision stratification of MPM patients based on HRR gene expression, potentially broadening PARP inhibitor applications.

• Cy7 NHS Ester: Protocols and QC for Near-Infrared Labeling

  2026-04-20

  Cy7 NHS ester is a sulfonated, hydrophilic near-infrared dye optimized for efficient, low-quenching labeling of proteins and peptides via amino groups. Its high water solubility and minimal need for organic solvents make it ideal for sensitive biomolecule conjugation and in vivo imaging. This reagent should not be used when long-term storage of dye solutions is required or when organic-only workflows are necessary.

• Iron Chelation Mitigates Nanoplastic-Induced Lung Fibroblast

  2026-04-19

  This study rigorously demonstrates that polystyrene nanoplastics (PS-NPs) drive pulmonary fibroblast proliferation and activation via iron ion accumulation, a process mediated through intercellular crosstalk with macrophages and epithelial cells. Pharmacological inhibition of iron accumulation significantly reduces fibroblast activation and pulmonary fibrosis, highlighting iron homeostasis as a tractable intervention point.

449 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page